Current through Register Vol. XLI, No. 50, December 13, 2024
Section 69-11-32 - Administrative Withdrawal32.1. Administrative withdrawal is an involuntary withdrawal or administrative discharge from pharmacotherapy. The schedule of withdrawal may be brief; less than 30 days, if necessary.32.2. MAT programs shall develop and implement policies and procedures for the involuntary termination from treatment that includes and describes the rights of the patient and the responsibilities and rights of the program.32.3. On admission, the patient shall be given a copy of the administrative withdrawal policies and procedures and shall sign a statement acknowledging receipt of the same. The signed acknowledgement shall be maintained in the patient's record.32.4. Administrative withdrawal may result from any of the following:32.4.a. Non-payment of fees. The MAT program shall make every effort to consider all clinical data, including patient participation and compliance with treatment prior to initiating administrative withdrawal for non-payment. If the patient has a history of compliance and cooperation with treatment, the program shall document every effort to explore alternatives to administrative withdrawal with the patient prior to onset of withdrawal. If necessary and unavoidable, the schedule of withdrawal shall follow protocols and guidelines of approved authorities.32.4.b. Disruptive or adverse effect conduct. Disruptive conduct or behavior considered to have an adverse effect on the program, clinical staff or patient population of such gravity as to justify the involuntary withdrawal and discharge of a patient. Such behaviors may include violence, threat of violence, dealing drugs, diversion of pharmacological agents, repeated loitering, failure to follow treatment plan objectives or noncompliance with program rules, policies and procedures resulting in an observable, negative impact on the program, staff and other patients.32.4.c. Incarceration or other confinement. The MAT program is responsible for working with law enforcement and corrections personnel in order to avoid mandatory withdrawal whenever possible.32.5. The MAT program shall document in the patient's individualized treatment plan of care and chart all efforts regarding referral or transfer of the patient to a suitable, alternative treatment program.32.6. Female patients shall have a negative pregnancy screen prior to the onset of administrative withdrawal.32.7. The program shall have in place a detailed relapse prevention plan developed by the counselor in accordance with approved national guidelines and in conjunction with the patient. The prevention plan shall be given to the patient in writing prior to the administration of the final dose of medication.W. Va. Code R. § 69-11-32